MustGrow Biologics Receives First Milestone Payment from Bayer Under EMEA Biocontrol License Agreement
Initial payment marks progress in mustard-based soil biocontrol technology collaboration valued up to $40 million over seven years
MustGrow Biologics Corp. has secured its first development milestone payment from Bayer AG pursuant to their December 2023 licensing and collaboration agreement. The deal grants Bayer rights to MustGrow’s mustard-based biocontrol technologies for soil applications across Europe, the Middle East, and Africa (EMEA). The…